Dublin biotech developing S1P receptor modulators for blood and bone-marrow cancers.
| Date | Round | Amount |
|---|---|---|
| Oct 2020 | Series A Dublin leukemia biotech Priothera raised a EUR30M Series A round led by Fountain Healthcare Partners. | $35M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.